business
LAC Adds MASQUELIER’S French Pine Bark Extract to Its Global Health Strategy
Thursday, August 27, 2026
LAC Global, the health and wellness supplements business of Singapore-based V3 Group, has completed its acquisition of MASQUELIER’S® French Pine Bark Extract, bringing the intellectual property and scientific heritage behind the long-established botanical ingredient into its portfolio.
The deal gives LAC control of the patented technology associated with MASQUELIER’S® and adds a product platform with more than seven decades of research history. It also comes as LAC expands its retail and e-commerce operations across Asia and looks for additional opportunities in international markets.
The acquisition is therefore about more than adding another supplement to LAC's lineup. It gives the Singapore-based company ownership of a recognized ingredient platform while strengthening its position in a wellness market increasingly focused on preventive health and healthy ageing.
Why is MASQUELIER’S French Pine Bark Extract significant?
MASQUELIER’S French Pine Bark Extract is based on oligomeric proanthocyanidins, or OPCs, a group of plant compounds belonging to the broader polyphenol family.
French scientist Professor Jack Masquelier played a major role in the early research and development of OPC extracts. The history of the MASQUELIER’S ingredient traces back to research conducted in France in the mid-20th century, including work involving the bark of the French Maritime Pine.
The company behind the ingredient says its extraction process focuses on a specific composition of OPCs rather than simply producing a general pine bark extract. Its published materials also describe testing and quality controls designed to maintain consistency between batches.
That distinction matters in the supplement business because botanical ingredients can vary depending on the plant source, extraction process and composition. Scientific reviews have likewise noted that commercially available pine bark extracts are not necessarily identical and that evidence can vary across formulations and health outcomes.
What are OPCs?
Oligomeric proanthocyanidins (OPCs) are naturally occurring plant compounds that are part of the proanthocyanidin family of polyphenols. They are studied for antioxidant activity and other biological effects. OPCs can occur in several plant sources, including grape seeds and pine bark.
For consumers, however, the term "antioxidant" should not automatically be interpreted as proof that a supplement prevents disease. Evidence for antioxidant supplements varies considerably depending on the specific compound, dose, formulation and health outcome being studied.
What does the acquisition mean for LAC?
For LAC, the acquisition provides an established ingredient platform that can be incorporated into its broader health and wellness portfolio.
According to the company, MASQUELIER’S French Pine Bark Extract has sold more than 250 million tablets to date. MASQUELIER’S® is also the originator and trademark holder of MASQUELIER’S® Anthogenol, an OPC supplement brand with a presence in Asia Pacific.
The move also fits into LAC's broader strategy of expanding beyond its original Singapore market.
LAC was established in 1997 and currently operates more than 250 branded stores across Singapore, Malaysia, the Philippines, Taiwan, China, Hong Kong and Vietnam, according to company information. Its distribution network also includes international markets.
The company said it has franchise operations in Mongolia, India, Indonesia and Thailand, while its products are available in selected markets outside Asia.
From retail expansion to intellectual property
The acquisition highlights a broader shift in how wellness companies can build their businesses.
Instead of relying entirely on developing new products internally, companies can expand by acquiring established brands, formulations or intellectual property. This can shorten the path to market while giving the acquiring company access to existing consumer recognition and research infrastructure.
For V3 Group, the transaction also strengthens the health and wellness component of a portfolio that spans several industries.
V3 Group founder and executive chairman Ron Sim said the acquisition brings European nutritional science into LAC while supporting the company's ambition to build a health and wellness business from Asia for global consumers.
Why Asia matters to LAC's expansion strategy
LAC's existing footprint gives the company a substantial base from which to grow.
Its physical stores provide direct access to consumers, while e-commerce allows the company to reach markets where establishing a full retail network may take longer.
The combination is particularly relevant in the supplements industry, where consumer trust can influence purchasing decisions. Physical retail allows consumers to interact with products and staff, while online channels make repeat purchases and cross-border access easier.
LAC's expansion also comes as wellness increasingly intersects with broader consumer concerns such as ageing, nutrition, fitness and preventive health.
However, growing demand does not remove the need for evidence. Consumers increasingly have access to health information online, making transparency around ingredients, clinical evidence, dosage and potential interactions more important.
What consumers should know about pine bark supplements
Research into pine bark extract has produced findings across several health areas, but the evidence should be interpreted carefully.
A 2020 Cochrane review examined 27 randomized controlled trials involving 1,641 participants across several chronic conditions. The researchers found that the studies varied substantially in quality, formulations and conditions studied, making broad conclusions difficult.
More recent research has continued to examine pine bark extract. A 2025 systematic review and meta-analysis covering 27 randomized trials and 1,685 participants reported improvements in several cardiometabolic measures, but the authors also called for larger, longer and higher-quality trials to confirm the findings.
That distinction is important. Research on pine bark extract in general should not automatically be treated as evidence for every commercial pine bark supplement or formulation.
Consumers should also remember that dietary supplements can interact with prescription medicines and other supplements. Health authorities recommend discussing supplement use with a doctor or pharmacist, particularly when a person is taking medication or undergoing medical treatment.
What comes next for LAC?
Following the acquisition, LAC plans to deepen its presence in existing markets while exploring further opportunities across Asia Pacific and internationally.
The company has identified preventive health, healthy ageing and everyday wellness as areas for continued product development.
For V3 Group, the strategy extends beyond geographic expansion. The company is combining an established Asian retail platform with intellectual property rooted in European nutritional research.
The bigger business question will be whether LAC can turn that combination into sustainable growth while maintaining scientific credibility as it enters more markets.
The bottom line
The LAC MASQUELIER’S French Pine Bark Extract acquisition marks a significant step in LAC Global's expansion from a regional supplement retailer into a broader health and wellness platform.
The deal brings an established botanical ingredient, intellectual property and decades of research history into LAC's portfolio. At the same time, the company's growing retail and e-commerce footprint gives it a platform for taking those products into more markets.
For consumers, the development is another sign of how the global wellness industry is evolving. Scientific heritage and brand recognition can help a supplement company grow, but long-term credibility will ultimately depend on product quality, transparent evidence and responsible health claims.












